63 Impact of randomised trial evidence and esc guideline change on practice of preventive pci in patients with ST-elevation myocardial infarction
dc.contributor.author | Hadyanto, S | en_US |
dc.contributor.author | Curtis, M | en_US |
dc.contributor.author | Wald, D | en_US |
dc.contributor.author | British Cardiovascular Society Annual Conference ‘Digital Health Revolution’ 3–5 June 2019 | en_US |
dc.date.accessioned | 2019-10-22T12:59:28Z | |
dc.date.issued | 2019-05-01 | en_US |
dc.identifier.issn | 1355-6037 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/60587 | |
dc.language.iso | en | en_US |
dc.publisher | BMJ Publishing Group | en_US |
dc.title | 63 Impact of randomised trial evidence and esc guideline change on practice of preventive pci in patients with ST-elevation myocardial infarction | en_US |
dc.type | Conference Proceeding | |
pubs.issue | Supplement 6 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 105 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |